The Alterations of Metabolic Adipo-myokines and Body Composition in End Stage Lung Cancer

NCT06060262 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2023-09-29

No results posted yet for this study

Summary

The investigators conduct this prospective study and wish to elucidate the association of serial change of body composition, serum adipo-myokines and adverse effect of chemotherapy and lung cancer prognosis

Conditions

  • Lung Cancer Metastatic

Sponsors & Collaborators

  • Chang Gung Memorial Hospital

    lead OTHER

Principal Investigators

  • TSENG CHIA-CHENG · Chang Gung Memorial Hospital

Eligibility

Min Age
20 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-02
Primary Completion
2025-11-30
Completion
2025-11-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06060262 on ClinicalTrials.gov